Display Settings:

Format

Send to:

Choose Destination

    Diabetes Care. 2009 Feb;32(2):308-10. Epub 2008 Nov 10.

    Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population.

    Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Sattar N.

    Faculty of Medicine, University of Glasgow, Scotland, UK. p.welsh@clinmed.gla.ac.uk

    OBJECTIVE: To clarify the association of circulating levels of leptin with risk for cardiovascular disease (CVD) events and new-onset diabetes in men and women. RESEARCH DESIGN AND METHODS: We related baseline leptin levels to CVD events (n = 864) and incident diabetes (n = 289) in an elderly population (n = 5,672) over 3.2 years of follow-up. RESULTS: In treatment-, age-, and country-adjusted models, leptin was not associated with risk of CVD in men (hazard ratio 1.02 [95% CI 0.90-1.16] per unit log-leptin increase) or women (1.05 [0.91-1.20]) but was associated with risk of diabetes in men (2.75 [2.14-3.52]) and women (1.54 [1.22-1.94]). After adjusting for classic risk factors and BMI, C-reactive protein, and glucose, the diabetes association retained significance in men (1.85 [1.30-2.63]) but not in women (0.89 [0.64-1.26]). CONCLUSIONS: Leptin, similar to other markers of adiposity in general, is more strongly related to risk of diabetes than CVD in the elderly.

    PMID: 19001191 [PubMed - indexed for MEDLINE]

    PMCID: 2628699

    Supplemental Content

    Click here to read